Stock.io

Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.

Novo Nordisk Raises Earnings Guidance. The Stock Sinks.

NVO Stock Drops 6% Despite Raised Guidance As Investors Worry About Injectable GLP-1 Sales Future

Novo Nordisk Boosts 2026 Adjusted Sales, Adjusted Operating Profit Guidance

Novo Nordisk: Q2 Earnings Snapshot